BPC-157 has not yet been tested in humans under controlled conditions
Extended 12-Week Protocol (Optional) Note: The 12-week extension reaches higher daily doses (10001300 mcg) explored in performance and metabolic research
BPC-157 peptide therapy may be suitable for adults seeking relief from musculoskeletal pain or injuries, joint concerns, digestive issues, chronic inflammation, or central nervous system (CNS) disorders.8 11 It could also potentially be used for neuroprotection, nerve regeneration, repairing organ damage from substance overdoses, healing lesions, and more.7 However, its again important to reiterate that nearly all of the above potential benefits of BPC-157 have not been demonstrated in human studies or trials
The trade-off is that thinner needles are slower to draw up medication and slightly more fragile
Not only will this reduce the risk of post-op infection of the wound site or the pancreas, it will also give your liver the chance to start healing